开发和免疫学的洞察力重组/亚单元疫苗针对禽类菌病的疫苗
Shagufta Iqbal1, Syed Tanveer1, Idrees Mehraj Allaie2
1Department of Zoology, University of Kashmir, Srinagar 190006, India.
Journal of microbiological methods
|September 13, 2025
概括
菌病会导致大量的家禽损失. 本次审查强调重组疫苗和免疫调节剂是打击耐药性的有希望的替代方案,并改善家禽对这种衰弱性疾病的免疫力.
科学领域:
- 禽畜科学 禽畜科学 禽畜科学
- 兽医免疫学 兽医免疫学
- 寄生虫学的寄生虫学
背景情况:
- 菌病对家禽业构成重大经济威胁.
- 抗虫药物耐药性和疫苗限制阻碍了有效的疾病控制.
- 替代策略对于管理家禽中的菌病至关重要.
研究的目的:
- 审查和突出新家禽菌病的新型控制策略.
- 探索免疫调节剂和重组疫苗的潜力.
- 评估增强宿主对菌病免疫力的方法.
主要方法:
- 文献综述侧重于免疫调节剂,辅助剂和复合/亚单位疫苗.
- 对菌病控制当前挑战的分析.
- 对替代疫苗接种策略的评估.
主要成果:
- 与辅助剂的重组/亚单元疫苗显示出对菌病控制的前景.
- 免疫调节提供了一个可行的机制来提高宿主抵抗力.
- 这些替代方案有可能减少经济损失.
结论:
- 再组合疫苗和免疫调节剂是菌病管理的有效替代策略.
- 增强宿主免疫力是减轻菌病影响的关键.
- 对这些替代品的进一步研究可以减轻家禽部门的财务负担.
相关概念视频
01:22Development of Immunocompetence
793
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
793
01:51Vaccinations
51.3K
Overview
51.3K
01:29Microorganisms in Medicine and Therapeutics
987
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
987